Lek Takeover: Novartis Says "No Comment" For Now
Basel, 27 September - Swiss drug-maker Novartis did not wish to comment immediately on the outcome of Friday's general assembly of takeover target Lek. The assembly rejected changes to the company's statute that were needed for Novartis to acquire Lek.
The rest of this news item is available to subscribers.
The news item consists of 198 characters (without spaces) or 38 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.